The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Trump set to deliver ‘historic’ speech celebrating America’s 250th anniversary
Paul Pelosi, 86, faces a hit-and-run charge after striking a parked car in Napa County: sheriff’s office
US celebrates its 250th birthday: PHOTOS
Library of Congress celebrates America 250 with massive birthday cake
America 250 around the world
Illegal immigrant truck driver charged in death of trooper who moved home to care for mom with cancer
Heat wave cancels some DC Independence Day celebrations
Two Americas: Mamdani and Trump give speeches ahead of Independence Day
Here Are 5 Insane Books Elementary Schools Are Offering Kids
The Answer To America’s Food Security Woes
Trump pardons 9 people convicted of tampering with emission controls on diesel engines
Pope Leo urges US to welcome immigrants in America 250 speech before visiting global migrant hotspot
New York Democrats’ Gerrymander: Too Little, Too Late And Too Expensive
OpenAI’s Sam Altman wants to negotiate a 5% stake in company for US if competitors agree to key provision
Court Looks to Decide Fate of ‘Decoy’ Candidate with Same Name as Senator
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Trump set to deliver ‘historic’ speech celebrating America’s 250th anniversary
Paul Pelosi, 86, faces a hit-and-run charge after striking a parked car in Napa County: sheriff’s office
US celebrates its 250th birthday: PHOTOS
Library of Congress celebrates America 250 with massive birthday cake
America 250 around the world
Illegal immigrant truck driver charged in death of trooper who moved home to care for mom with cancer
Heat wave cancels some DC Independence Day celebrations
Two Americas: Mamdani and Trump give speeches ahead of Independence Day
Here Are 5 Insane Books Elementary Schools Are Offering Kids
The Answer To America’s Food Security Woes
Trump pardons 9 people convicted of tampering with emission controls on diesel engines
Pope Leo urges US to welcome immigrants in America 250 speech before visiting global migrant hotspot
New York Democrats’ Gerrymander: Too Little, Too Late And Too Expensive
OpenAI’s Sam Altman wants to negotiate a 5% stake in company for US if competitors agree to key provision
Court Looks to Decide Fate of ‘Decoy’ Candidate with Same Name as Senator
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
